TY  - GEN
AU  - Markham,A
TI  - Benralizumab: First Global Approval
SN  - 1179-1950
PY  - 2019///0405
KW  - Administration, Inhalation
KW  - Anti-Asthmatic Agents
KW  - administration & dosage
KW  - Antibodies, Monoclonal, Humanized
KW  - Asthma
KW  - drug therapy
KW  - Drug Approval
KW  - Humans
KW  - Interleukin-5 Receptor alpha Subunit
KW  - immunology
KW  - Male
KW  - Pulmonary Disease, Chronic Obstructive
KW  - Pulmonary Eosinophilia
KW  - Treatment Outcome
KW  - United States
KW  - United States Food and Drug Administration
N1  - Publication Type: Journal Article; Review
UR  - https://doi.org/10.1007/s40265-018-0876-8
ER  -